SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sudarshan Pharma Industries enters into Rent Agreement with Daundi Biological

07 Jan 2025 Evaluate

Sudarshan Pharma Industries has entered into a Rent Agreement with Daundi Biological to acquire premises for a period of 5 years commencing from December 29, 2024 to set up a new Research & Development formulation centre in the city of Dehradun, Uttarakhand, India. It is expected to commence the operations of the formulation R&D Centre in the month of March 2025. 

Sudarshan Pharma Industries is engaged in contract manufacturing, outsource & Supply of Generic Pharma formulation and medicines to healthcare institution, Government, NGO and Hospitals.


Sudarshan Pharma Ind Share Price

30.00 -0.90 (-2.91%)
16-Apr-2026 13:29 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1678.65
Dr. Reddys Lab 1222.00
Cipla 1230.55
Zydus Lifesciences 937.65
Lupin 2309.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×